PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,922,760 | +15.7% | 122,854 | +17.8% | 0.04% | +9.4% |
| Q1 2023 | $4,254,769 | +5.6% | 104,258 | -0.1% | 0.03% | +3.2% |
| Q4 2022 | $4,029,764 | -72.5% | 104,371 | -62.1% | 0.03% | -74.4% |
| Q3 2022 | $14,651,000 | -13.4% | 275,451 | -5.1% | 0.12% | -6.2% |
| Q2 2022 | $16,925,000 | -25.6% | 290,310 | -2.7% | 0.13% | -12.8% |
| Q1 2022 | $22,761,000 | +6.7% | 298,236 | -15.9% | 0.15% | +9.6% |
| Q4 2021 | $21,337,000 | +38.0% | 354,606 | +28.5% | 0.14% | +29.8% |
| Q3 2021 | $15,459,000 | -12.9% | 276,047 | -5.6% | 0.10% | -10.3% |
| Q2 2021 | $17,752,000 | -19.0% | 292,556 | -6.5% | 0.12% | -21.6% |
| Q1 2021 | $21,927,000 | -13.0% | 312,844 | -25.7% | 0.15% | -19.6% |
| Q4 2020 | $25,191,000 | +4.9% | 420,967 | +5.4% | 0.18% | -10.7% |
| Q3 2020 | $24,007,000 | +130.5% | 399,319 | +101.2% | 0.21% | +123.9% |
| Q2 2020 | $10,413,000 | +53.8% | 198,448 | -1.7% | 0.09% | +26.0% |
| Q1 2020 | $6,772,000 | -15.6% | 201,981 | +14.0% | 0.07% | +17.7% |
| Q4 2019 | $8,027,000 | +14.1% | 177,198 | -4.1% | 0.06% | +6.9% |
| Q3 2019 | $7,032,000 | – | 184,720 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |